Viewing Study NCT01648192


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2025-12-31 @ 9:39 PM
Study NCT ID: NCT01648192
Status: COMPLETED
Last Update Posted: 2017-07-26
First Post: 2012-07-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of GW856553 (Losmapimod)
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module